Publication Name	World Journal of Hepatology
Manuscript ID	64621
Country	Spain

Received	2021-02-21 18:09
Peer-Review Started	2021-02-21 18:16
To Make the First Decision
Return for Revision	2021-06-04 05:08
Revised	2021-06-17 20:34
Second Decision	2021-08-23 02:39
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-23 05:48
Articles in Press	2021-08-23 05:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-09-05 20:13
Typeset the Manuscript	2021-10-19 02:12
Publish the Manuscript Online	2021-10-22 13:53

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	COVID-19 in liver transplant patients: Clinical and therapeutic aspects
Manuscript Source	Invited Manuscript
All Author List	Carmelo Loinaz-Segurola, Alberto Marcacuzco-Quinto and Mario Fernández-Ruiz
ORCID	Author(s) ORCID Number Carmelo Loinaz-Segurola http://orcid.org/0000-0002-1873-0568 Alberto Marcacuzco-Quinto http://orcid.org/0000-0001-6266-8792 Mario Fernández-Ruiz http://orcid.org/0000-0002-0315-8001
Funding Agency and Grant Number
Corresponding Author	Carmelo Loinaz-Segurola, FACS, MD, PhD, Associate Professor, HBP and Transplant Surgery Unit. Department of General Surgery, Digestive Tract and Abdominal Organ Transplantation, Hospital Universitario “12 de Octubre”, Instituto de Investigación Sanitaria Hospital “12 de Octubre” (imas12), Universidad Complutense, Avenida de Cordoba s/n, Madrid 28041, Spain. cloinaz@ucm.es
Key Words	COVID-19; Liver transplantation; Clinical features; Therapy; Immunosuppression; SARS-CoV-2
Core Tip	Coronavirus disease 2019 incidence and clinical and radiological features are similar in liver transplant recipients and the general population. Reported mortality in hospitalized patients is 12%-19%. Risk factors are older age and comorbidity. Tacrolimus could be protective, but anti-proliferative such as mycophenolate mofetil should be avoided.
Publish Date	2021-10-22 13:53
Citation	Loinaz-Segurola C, Marcacuzco-Quinto A, Fernández-Ruiz M. COVID-19 in liver transplant patients: Clinical and therapeutic aspects. World J Hepatol 2021; 13(10): 1299-1315
URL	https://www.wjgnet.com/1948-5182/full/v13/i10/1299.htm
DOI	https://dx.doi.org/10.4254/wjh.v13.i10.1299

Full Article (PDF)	WJH-13-1299.pdf
Full Article (Word)	WJH-13-1299.docx
Manuscript File	64621-Review-FilipodiaCL.docx
Answering Reviewers	64621-Answering reviewers.pdf
Audio Core Tip	64621-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	64621-Conflict-of-interest statement.pdf
Copyright License Agreement	64621-Copyright license agreement.pdf
Peer-review Report	64621-Peer-review(s).pdf
Scientific Misconduct Check	64621-Scientific misconduct check.pdf
Scientific Editor Work List	64621-Scientific editor work list.pdf
CrossCheck Report	64621-CrossCheck report.pdf